An incorporation study of [1-13 C] and [1,2-13 C 2 ] labeled sodium acetates into sorbicillinol 1 established a ring closure system between C-1 and C-6 and the positions that were oxidized and W or methylated on a hexaketide chain. Subsequent investigations, using 13 C-labeled 1 prepared from [1-13 C] labeled sodium acetate, clearly demonstrated that both bisorbicillinol 2 and sorbicillin 6 incorporated 13 C-labeled 1 into their carbon skeletons. 13 C-labeled bisorbicillinols 2 derived from [1-13 C]-and [2-13 C]-labeled sodium acetates clearly indicate that these were on the biosynthetic route from 1 to bisorbibutenolide (bislongiquinolide) 3 and bisorbicillinolide 4 via 2 as a branching point in the fungus.
The``bisorbicillinoids'' 1) is a term for all dimeric sorbicillin-derived natural products, e.g. bisvertinoquinol, 2, 3) bisvertinols, 4) bisvertinolone, [4] [5] [6] trichodimerol, [6] [7] [8] trichodermolide, 9) sorbiquinol, 9) bisorbibutenolide (bislongiquinolide) 3, [10] [11] [12] trichotetronines, 13 ) bisorbicillinol 2, 6) demethyltrichodimerol, 6) bisorbicillinolide 4, 11) and bisorbibetanone, 14) isolated from a few fungal genera. We have recently presented our HPLC analysis of the yellowish metabolites produced by Trichoderma sp. USF-2690 and showed that an unidentiˆed major metabolite accumulated in the early stage of fermentation and gradually decreased with bisorbicillinoid production. We thought that this metabolite, designated as sorbicillinol 1 (Fig. 1 ), must be a key intermediate of bisorbicillinoid biosynthesis. Our detailed chemical investigation of sorbicillinol 1 established its structure, together with the absolute stereochemistry, as (6S )-4-(2,4-hexadienoyl)-3,6-dihydroxy-2,6-dimethyl-2,4-cyclohexadien-1-one, which was a hypothetical quinol intermediate that has been postulated for the last 20 years. 15, 16) We propose that the group of hexaketide compounds having a sorbyl chain and isolated from bisorbicillinoid-producing strains should be termed``sorbicillinoid''. A study on the chemical conversion of a sorbicillinoid, sorbicillinol 1, strongly supported the biogeneses from 1 to bisorbicillinol 2 and from 1 to trichodimerol. In addition, our primary communication has shown evidence that the biosynthetic routes from bisorbicillinol 2 to bisorbibutenolide 3 and from 2 to bisorbicillinolide 4 existed in Trichoderma sp. USF-2690. 17) In the work reported here, the biosynthesis of sorbicillinol 1, using [1,2- 13 C2]-and [1-13 C]-labeled sodium acetate, is investigated. Subsequently, to establish their biological pathway, either 13 C-labeled sorbicillinol 1 or 13 Clabeled bisorbicillinol 2 was employed as a precursor of the metabolites following on in the bisorbicillinoid biosynthesis.
Materials and Methods
Chemicals. Sodium [1- 13 C] acetate, sodium [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C] acetate, sodium [1,2- 13 C2] acetate and the other commercially available reagents were purchased from Aldrich Chemical Co. and Wako Pure Chemical Industries.
General procedure and instruments. NMR measurements were taken with a Jeol alpha-400 spectrometer at 400 MHz for 1 H and at 100 MHz for 13 C. All chemical shifts are with reference to the signal for tetramethylsilane (d H ＝d C ＝0). Analytical HPLC was carried out with Jasco PU-980 pump connected to a Jasco UV-970 spectrometer and Shiseido Capcell pak C18 SG120 column (4.6q×150 mm). A 10-ml aliquot of theˆltered fermentation broth was directly injected into the analytical HPLC system under the following conditions: column Capcell pak C18 SG120; solvent system, a 0.15z KH2PO4 (pH 3.5) solution (solvent A) and CH3CN (solvent B), a gradient pro- gram made up linear segments with 40z of solvent B (from 0 to 10 min), from 40z to 60z of solvent B (from 10 to 20 min) and with 60z of solvent B (from 20 to 25 min); ‰ow rate, 1.0 ml W min; detection, UV at 370 nm. Preparative HPLC was carried out with a Jasco 880-PU pump connected to the Jasco UV-970 spectrometer and to a Shiseido Capcell pak C18 SG120 column (15q×250 mm). A 500-ml aliquot of the sample dissolved in methanol was injected into the preparative HPLC system under the following conditions: column Capcell pak C 18 SG120; solvent system, (A) 0.15z KH2PO4 (pH 3.5)-CH3CN (6:4) or (B) H2O-CH3CN (1:1, containing 0.1z tri‰uoro-acetic acid); ‰ow rate, 8.0 ml W min; detection, UV at 370 nm. MPLC was performed with a Yamazen YFLC-600A pump connected to a Yamazen UV-10V spectrometer under the following conditions: support, YMC-ODS-AQ 120-S50 (25q×350 mm); solvent system, (B) or (C) H2O-CH3CN (4:6, containing 0.1z tri‰uoroacetic acid); detection, UV at 370 nm.
Fermentation. The fungal strain classiˆed as Trichoderma sp. USF-2690 was cultivated on a reciprocal shaker at 309 C in 0.5-liter ‰asks, each containing 100 or 150 ml of a medium of 2z glucose, 0.05z polypeptone, 0.2z yeast extract, 0.1z KH2PO4, 0.1z MgSO4 ・7H 2 O, and 0.1z trace salt mixture (0.064z CuSO4 ・5H 2 O, 0.011z FeSO4 ・ 7H2O, 0.079z MnCl2 ・4H 2 O, and 0.015z ZnSO4 ・ 7H2O) at pH 7.0.
Procedure for preparing washed mycelia. The fungus was incubated in ten 0.5-liter ‰asks, each containing 150 ml of a medium (pH 7) composed of 2.0z glucose and 0.5z polypeptone, on a reciprocal shaker at 309 C for 9 days. The resulting mycelia were washed with sterilized water (500 ml×4) to givè`w ashed mycelia''.
General puriˆcation procedure. Theˆltered broth was adjusted to pH 3 with HCl and then extracted with half the volume of ethyl acetate (×2). The organic extract, which had been concentrated in vacuo, was applied to (I) a Sephadex LH-20 column (25q× 500 mm, eluted with CH 3 OH) or (II) the preparative HPLC column under the conditions already described.
Preparation of labeled sorbicillinol 1. The fungus was preincubated in two 0.5-liter ‰asks each containing 100 ml of the medium under the above-mentioned conditions for 40 hr. One hundred milligrams of sodium [1,2-13 C2] acetate was then added to each bottle, and additional fermentation was carried out for 24 hr. Theˆltered broth (200 ml) that had been cultured was concentrated in vacuo to 20 ml. The concentrated aqueous solution was applied to a Sephadex LH-20 column (25q×500 mm) and eluted with H2O. The desired fraction (70 ml), including sorbicillinol 1 ([1,2-13 C 2 ]SA-1) of 60z purity, was obtained from the HPLC analysis. The experiment with sodium [1- 13 C] acetate gave 13 C-labeled 1 ([1-13 C]SA-1) in the same manner.
6-O-Acetylation of
13 C-labeled sorbicillinol 1. The aqueous sorbicillinol ( [1,2- 13 C2]SA-1) fraction (70 ml) was added to 380 ml of acetic anhydride while stirring for 1 hr at ambient temperature. After the reaction mixture had turned into a pale yellow homogeneous solution, 380 ml of pyridine was added, and the mixture was stirred for 1 hr more. The resulting solution was poured into 10 l of distilled water, extracted with 4 l of CHCl3, and dried over Na2SO4. The concentrate puriˆed by preparative TLC (Merck Art No. 13794, n-hexane W EtOAc＝1:1) gave 125.6 mg of crude 6-O-acetylsorbicillinol 5. Finally, preparative HPLC with solvent system A gave 11.6 mg of 5 ([1,2- Incorporation of labeled sorbicillinol 1 into bisorbicillinol 2 and sorbicillin 6. The fungus was preincubated in two 0.5-liter ‰asks containing 50 ml of the medium under the above-mentioned conditions for 3 days. Fifty milliliter of an aqueous sodium [1- 13 C] acetate-free solution including 13 C-labeled sorbicillinol 1 (650 mM) derived from sodium [1- 13 C] acetate ([1-
13 C]SA-1) was added to each ‰ask. Additional fermentation was conducted for 2 days. Theˆltered broth (200 ml) was puriˆed according to general puriˆcation procedure II, using solvent system B, to give 18.0 mg of 13 Preparation of labeled bisorbicillinol 2. The washed mycelia from the procedure already described were suspended in six 0.5-liter ‰asks, each holding 150 ml of the medium (pH 7) supplemented with 150 mg of sodium [1- 13 C] acetate and 0.5z polypeptone, and then fermented with reciprocal shaking at 309 C for 2 days. After applying general preparation procedure I as described, the fraction including 2 (68.3 mg) was rechromatographed by MPLC with solvent system B. Pure bisorbicillinol 2 ([1-
13 C]SA-2, 9.3 mg) was given as a yellowish amorphous powder. The experiment with sodium [2- 13 C] acetate gave 13 C-labeled 2 ([2-13 C]SA-2) in the same manner.
Bioconversion study on bisorbicillinol 2, bisorbibutenolide 3, and bisorbicillinolide 4. The washed mycelia from the procedure already described were inoculated into three 0.5-liter ‰asks each containing 150 ml of sterilized water, and either 24.0 mg of bisorbicillinol 2, 20.8 mg of bisorbibutenolide 3, or 1.0 mg of bisorbicillinolide 4. Each culture was incubated on a reciprocal shaker at 309 C and monitored after 0, 2, 4, 6, 8, and 24 hr by HPLC under the conditions just described.
Incorporation of labeled bisorbicillinol 2 into bisorbibutenolide 3 or bisorbicillinolide 4. The washed mycelia from the procedure already described were inoculated into two 0.5-l ‰asks each containing 150 ml of sterilized water and 10 mg of non-labeled and 5 mg of 13 C-labeled bisorbicillinol 2 ([1-13 C]SA-2). Each culture broth for isolating bisorbibutenolide 3 or bisorbicillinolide 4 was aŠorded after culturing for 72 hr and 10 hr, respectively. Theˆltrate (200 ml) obtained from each broth was puriˆed according to general puriˆcation procedure II, using solvent system B for 3 and C for 4. Pure bisorbibutenolide 3 ([1-13 C]SA-2-3, 7.5 mg) and pure bisorbibutenolide 4 ([1-
13 C]SA-2-4, 0.6 mg) were each given as a yellowish amorphous powder. The experiment with [2-13 C]SA-2 gave 13 C-labeled 3 ([2-13 C]SA-2-3) and 13 Clabeled 4 ([2-
13 C]SA-2-4) in the same manner. 13 C2] acetate, gave sorbicillinol 1 after puriˆca-tion by aqueous Sephadex LH-20 column chromatography. In this context, it is important to note that sorbicillinol 1 was not directly suitable for 13 Cs 1 Ht -NMR measurement because it was too reactive to be stable in the concentrated solution required for NMR; therefore, 1 was converted into stable 6-Oacetyl derivative 5 in an aqueous solution as soon as possible. 15) Enhanced signals in the 13 Cs 1 Ht -NMR spectrum were observed in resulting acetate 5, compared with unlabeled control 5 ( Table 1 ). In the 13 Cs 1 Ht -NMR spectrum of 6-O-acetylsorbicillinol 5 derived from sodium [1- 13 C] acetate, labeling was observed at C-1, C-3, C-5, C-1?, C-3?, and C-5?. On the other hand, the one-bond 13 C-13 C coupling constants ( 1 JC-C) in the 13 Cs 1 Ht -NMR spectrum and 13 C-13 C correlation observed in the INADEQUATE spectrum of acetate 5 incorporating sodium [1,2- 13 C2] acetate indicate that six acetate units were incorporated for C-1 W C-6, C-2 W C-3, C-4 W C-5, C-1? W C-2?, C-3? W C-4?, and C-5? W C-6?. The incorporation pattern obtained from these feeding experiments led to the unambiguous head-to-tail form typical of fatty acids and polyketides; therefore, it was established that methylation at C-4 and C-6 and then ring closure between the carbonyl end (C-1) and C-2 in a hexaketide chain and subsequent reduction at C-1 had oc- curred, and C-6 was oxidized during these events. Thisˆnding also indicates that biosynthetic route A (Fig. 2 ) might exist in Trichoderma sp. USF-2690; that is, neither feasible route B via compound 8 as a precursor nor route C that has previously been proposed by Trifonov et al. 2) were ruled out by the incorporation pattern of double-labeled acetate 5?.
Results and Discussion

C-Labeled sorbicillinol 1 incorporated into sorbicillin 6
The results of the incorporation experiments of the [1,2-
13 C2]-and [1-13 C]-labeled sodium acetates into sorbicillinol 1 suggested the possibility that sorbicillin 6 was biosynthesized from sorbicillinol 1. Accordingly, we tried to conˆrm this possibility. A feeding experiment of [1- 13 C]SA-1 to sorbicillin 6 was performed by fermentation in the medium including [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]SA-1 and puriˆcation by the use of preparative HPLC. The 13 Cs 1 Ht -NMR spectrum of obtained sorbicillin 6 displayed signiˆcant 13 C-enrichment of C-1, C-3, C-5, C-1?, C-3?, and C-5? (Fig. 3) . The resulting observation of the high incorporation level of [1- 13 C]SA-1 into 6 established at least the existence of a biosynthetic route from sorbicillinol 1 to sorbicillin 6 in Trichoderma sp. USF-2690. . The numbers in parentheses express the increase in the height of the 13 C resonance relative to that of unlabeled sorbicillin 6, after correction by standardizing the two samples with the mean peak height for all unlabeled carbons. 2 derived from sodium [1-13 C] acetate ([1-13 C]SA-2) showed ten 13 C-enriched carbons (C-1, C-3, C-5, C-7, C-1?, C-3?, C-5?, C-1!, C-3!, and C-5!), excepting invisible C-9 and C-11, which were correlated with keto-enol tautomerism. 6) On the other hand, bisorbicillinol 2 derived from sodium [2- 13 C] acetate ([2-13 C]SA-2) gave a 13 Cs 1 Ht -NMR spectrum having 12 enhanced peaks at C-2, C-4, C-6, C-8, C-10, C-12, C-2?, C-4?, C-6?, C-2!, C-4!, and C-6! which were estimated by the rate of 13 C-incorporation of each carbon (Fig. 4) Ht -NMR spectra mean that the bonds between C-1 and C-7 (both carbons were derived from the carbonyl carbon at C-1 of the acetate) and between C-4 and C-8 (both from the methyl carbon at C-2 of the acetate) were formed by two hexaketide components combined in head-to-tail manner. Moreover, sorbicillinol 1 as a precursor of bisorbicillinol 2 was ascertained by the incorporation of 13 C-labeled 1 derived from sodium [1- 13 C] acetate ([1-
13 C]SA-1) into 2. As expected, 13 C-labeled 2 ([1-13 C]SA-1-2) revealed the same labeling pattern as that of [1- 13 C]SA-2 (Fig. 5) .
Biosynthesis from bisorbicillinol 2 to bisorbibutenolide (bislongiquinolide) 3
The structural relevance between bisorbicillinol 2 and bisorbibutenolide 3 led us to hypothesize that 3 might be biosynthesized from 2, although Sperry et al. 12) and Shirota et al. 13) have proposed that 3 was formed by a Diels-Alder reaction between a dehydrated derivative of 5-hydroxyvertinolide 10) as a dienophile and sorbicillinol 1 as a diene. We expected that the hydroxyl group at C-12 of 2 as a nucleophile attacked the carbonyl carbon at C-9, this being followed by cleavage of the bond between C-8 and C-9, in the formation of 3.
11) The bioconversion study on bisorbicillinol 2, using washed mycelia of Trichoderma sp. USF-2690, revealed two major metabolites in the incubation mixture from the analysis by HPLC, while the supporting experiments might rule out the possibility of biosynthesis from bisorbicillinol 2 to bisorbibutenolide 3 via bisorbicillinolide 4 or from 2 to 4 via 3 and the reverse biosynthesis from 3 or 4 to 2. In the case of bisorbicillinol 2, these metabolites showed the same retention times as those of bisorbibutenolide 3 (tR＝15.8 min) and bisorbicillinolide 4 (tR＝23.2 min) by HPLC. The succeeding incorporation, employing [1- 13 C]SA-2 and [2-13 C]SA-2, respectively, as the starting material, also showed the same proˆles by the HPLC analyses. The 1 H-NMR spectra of the isolated metabolites (50.0z conversion ratio) observed at 15.8 min identiˆed bisorbibutenolide 3. In the 13 Cs 1 Ht -NMR spectrum of 3 incorporating [1-13 C]SA-2, labeling was detected as intense singlets at C-1, C-3, C-5, C-7, C-10, C-12, C-1?, C-3?, C-5?, C-1!, C-3!, and C-5!, while, in the case of feeding [2- 13 C]SA-2, the 13 Cs 1 Ht -NMR spectrum of 3 revealed twelve 13 C-enriched peaks at C-2, C-4, C-6, C-8, C-9, C-11, C-2?, C-4?, C-6?, C-2!, C-4!, and C-6! (Fig. 6 ). These labeling patterns strongly conrmed the operation of our expected biosynthetic pathway from bisorbicillinol 2 to bisorbibutenolide 3 according to the events already described.
Biosynthesis from bisorbicillinol 2 to bisorbicillinolide 4
Another metabolite (tR＝23.2 min, 4.0z conversion ratio) isolated from the incubation mixture in- Ht -NMR spectrum which was strongly labeled at C-2, C-4, C-5, C-7, C-9, C-11, C-2?, C-4?, C-6?, C-2!, C-4!, and C-6! (Fig. 7) . The intact incorporation of the 13 C-enriched carbons of each bisorbicillinol 2 into corresponding bisorbicillinolide 4 strongly support 2 as being a direct precursor of 4. The incorporation pattern from 2 to 3 and that from 2 to 4 are summarized in Fig. 8 .
Proposed biosynthetic pathway
In our stepwise incorporation studies, starting from 13 C-labeled acetates, on bisorbicillinoid biosynthesis, a biosynthetic pathway from sorbicillinol 1 to bisorbibutenolide 3 and bisorbicillinolide 4 was unambiguously established by measuring the 13 Cs 1 Ht -NMR spectrum of each 13 C-enriched metabolite. The proposed biosynthetic pathway from six acetates is outlined in Fig. 9 .
The incorporation pattern of six acetate units in 5 provides important information on the formation of sorbicillinol 1 in Fig. 2 . Trifonov et al. have reported 2,4) that 1 was derived from sorbicillin 6, the formation of which could be explained in a straightforward way on a hexaketide: (1) methylation at C-4 and C-6, (2) reduction at C-1 and dehydration between C-1 and C-2, and (3) condensation between C-2 and C-3. The incorporation of [1,2- 13 C2] acetate units into the benzene moiety of 5 reveals that the units were introduced in the opposite sense (5?); therefore, this route (route C in Fig. 2 ) is precluded. The second route (a and b in Fig. 2) is the most appropriate one, giving compound 8 as a precursor biosynthesized via Claisen-type ring closure and spontaneous aromatization. On symmetrical molecule 8, C-1 and C-3 and C-4 and C-6 were indistinguishable. Consequently, Fig. 2 ) via 8 was also excluded. The third route (route A in Fig. 2 ) to give true 13 Cincorporated sorbicillinol ([1,2-
13 C2]SA-1) needed Claisen-type ring closure between C-1 and C-2 and successive reduction at C-1 that was sharply diŠeren-tiated between C-1 and C-3. The feature of this route led us to believe that a biosynthetic mechanism was in operation, in which oxidation at C-6 might take place before ring closure or both reactions might have occurred at the same time. The result of the incorporation study of [1- 13 C]SA-1 into sorbicillin 6 supports the possibility that sorbicillin 6 was merely a terminal metabolite in the biosynthesis, although the possibility of the route from 6 to 1 was not excluded. In this investigation, the unexpected labeling pattern of [1,2-13 C2]SA-1 provides attractive possibilities for the formation of sorbicillinol 1.
18) The so-called`black box' involving routes I and II (Fig. 9 ) has remained to be elucidated.
The biosynthetic pathway from sorbicillinol 1 to bisorbicillinol 2 was established by the intact incorporation of two molecules of 13 Ht -NMR spectra of two main metabolites generated in each 13 Cfeeding experiment indicate that the washed mycelia of Trichoderma sp. USF-2690 converted bisorbicillinol 2 into bisorbibutenolide 3 (50.0z conversion ratio) and bisorbicillinolide 4 (4.0z conversion ratio). Furthermore, the results of bioconversion studies on bisorbicillinol 2, bisorbibutenolide 3 and bisorbicillinolide 4 indicate that 2 was located at a branching point between the biosynthetic pathway to 3 and that to 4. The presence of two anions as biosynthetic intermediates induced from bisorbicillinol 2 was presumed from the structures of bisorbibutenolide 3 and bisorbicillinolide 4 (Fig. 9) . That is, nucleophilic attack from the hydroxyl group at C-12 of 2 on the carbonyl carbon at C-9 with cleavage of the bond between C-8 and C-9 may form theˆrst anion generated at C-8. The anion at C-8 would catch a proton and then give bisorbibutenolide 3, while a subsequent nucleophilic reaction between the anion at C-8 and a carbonyl at C-5 and then cleavage of the bond between C-4 and C-5 may yield the second anion at C-4 of 2. The formation of bisorbicillinolide 4 would be achieved by a Michael-type reaction of the second anion at C-4 with C-9.
In conclusion, the results of our investigation on the stepwise 13 C-incorporation starting from 13 C-labeled sodium acetates show the operation of biosynthetic routes from sorbicillinol 1 to sorbicillin 6 and to bisorbicillinol 2, and subsequent routes from bisorbicillinol 2 to bisorbibutenolide 3 and to bisorbicillinolide 4 for bisorbicillinoid biosynthesis. Thiŝ nding prompts the question of which mechanism works for the production of sorbicillinol 1 from a hexaketide, and this is now under investigation. Another important point is evidence for the route from bisorbicillinol 2 to bisorbibutenolide 3. A diŠerent biosynthetic route to bisorbibutenolide (bislongiquinolide) 3 has previously been proposed by Sperry et al. 12) and Shirota et al. 13) However, our incorporation study has conˆrmed that a new biosynthetic route to bisorbibutenolide 3 existed in Trichoderma sp. USF-2690.
